Bispham Barbara Harlin bought CBIO
December 15, 2025 · Form 4 insider transaction
Bispham Barbara Harlin bought 72,185 shares of Crescent Biopharma, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
72,185
Price
$0.00
Total value
N/A
InsiderBispham Barbara Harlin
Role—
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateDecember 15, 2025
Filing dateDecember 17, 2025
Shares owned after72,185
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This Option represents a right to purchase shares of the Issuer's Ordinary Shares and vests with respect to 1/48th of the Option on each monthly anniversary of December 15, 2025, subject to the Reporting Person remaining continuously employed by or providing services to the Issuer or its subsidiaries from December 15, 2025 through each such vesting date.